Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 24% ± 5% | |
lung | 11 studies | 24% ± 9% | |
intestine | 6 studies | 22% ± 8% | |
lymph node | 5 studies | 26% ± 7% | |
kidney | 4 studies | 21% ± 4% | |
liver | 4 studies | 27% ± 14% | |
pancreas | 3 studies | 50% ± 19% | |
eye | 3 studies | 31% ± 12% | |
brain | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3547.93 | 258 / 258 | 100% | 157.31 | 230 / 230 |
esophagus | 100% | 3260.89 | 1445 / 1445 | 100% | 103.91 | 183 / 183 |
kidney | 100% | 3203.17 | 89 / 89 | 100% | 102.92 | 901 / 901 |
liver | 100% | 2669.65 | 226 / 226 | 100% | 145.13 | 406 / 406 |
lung | 100% | 2833.69 | 578 / 578 | 100% | 143.60 | 1155 / 1155 |
ovary | 100% | 3752.63 | 180 / 180 | 100% | 164.31 | 430 / 430 |
pancreas | 100% | 2743.60 | 328 / 328 | 100% | 104.36 | 178 / 178 |
prostate | 100% | 3530.40 | 245 / 245 | 100% | 129.57 | 502 / 502 |
uterus | 100% | 3283.87 | 170 / 170 | 100% | 140.19 | 459 / 459 |
skin | 100% | 3093.90 | 1808 / 1809 | 100% | 168.27 | 472 / 472 |
brain | 100% | 3045.08 | 2640 / 2642 | 100% | 127.42 | 705 / 705 |
breast | 100% | 3273.16 | 459 / 459 | 100% | 168.46 | 1117 / 1118 |
thymus | 100% | 3373.77 | 653 / 653 | 100% | 129.33 | 604 / 605 |
intestine | 100% | 3270.12 | 966 / 966 | 100% | 111.35 | 525 / 527 |
stomach | 100% | 3049.22 | 359 / 359 | 99% | 106.08 | 284 / 286 |
bladder | 100% | 3451.48 | 21 / 21 | 99% | 121.70 | 499 / 504 |
adipose | 100% | 3123.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3566.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 124.61 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 145.90 | 29 / 29 |
muscle | 100% | 5707.37 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3404.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 122.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.42 | 1 / 1 |
heart | 99% | 4856.74 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2430.76 | 894 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903214 | Biological process | regulation of protein targeting to mitochondrion |
GO_0110053 | Biological process | regulation of actin filament organization |
GO_0030833 | Biological process | regulation of actin filament polymerization |
GO_0030854 | Biological process | positive regulation of granulocyte differentiation |
GO_1903146 | Biological process | regulation of autophagy of mitochondrion |
GO_0007005 | Biological process | mitochondrion organization |
GO_0038158 | Biological process | granulocyte colony-stimulating factor signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000932 | Cellular component | P-body |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005938 | Cellular component | cell cortex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0030027 | Cellular component | lamellipodium |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0019966 | Molecular function | interleukin-1 binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HAX1 |
Protein name | HCLS1 associated protein X-1 isoform 1 HCLS1 associated protein X-1 HCLS1 associated protein X-1 isoform 3 HCLS1-associated protein X-1 (HS1-associating protein X-1) (HAX-1) (HS1-binding protein 1) (HSP1BP-1) HCLS1 associated protein X-1 isoform 5 HCLS1-associated protein X-1 (HS1-associating protein X-1) |
Synonyms | HS1BP1 |
Description | FUNCTION: Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex . Slows down the rate of inactivation of KCNC3 channels . Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools. . FUNCTION: Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex. Slows down the rate of inactivation of KCNC3 channels. Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools. . FUNCTION: Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex. Slows down the rate of inactivation of KCNC3 channels. Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools. . |
Accessions | A0A8V8TKG6 ENST00000696932.1 [O00165-1] ENST00000447768.7 [O00165-6] ENST00000696944.1 ENST00000435087.2 A0A8V8TLX9 ENST00000532105.1 ENST00000328703.12 [O00165-1] A0A8V8TLZ3 ENST00000696965.1 ENST00000697830.1 [O00165-3] A0A8V8TKI6 A0A0S2Z565 ENST00000696933.1 Q5VYD6 A0A8V8TKI8 ENST00000696941.1 [O00165-3] A0A8V8TKG3 A0A0S2Z591 ENST00000696929.1 A0A0S2Z519 ENST00000696938.1 O00165 ENST00000696945.1 ENST00000483970.7 [O00165-2] A0A8V8TKH7 ENST00000457918.6 [O00165-5] ENST00000696966.1 E9PIQ7 ENST00000697592.1 [O00165-3] |